Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Sustained buying fuels indices
Thu, 7 Jun Closing

Indian equity markets traded firm throughout the trading session today on the back of sustained buying activity across index heavyweights. Although trading was largely rangebound in the morning session, buying pace picked up post noon. The final hours saw the indices inch upwards to close well above the dotted line. While the Sensex today closed higher by around 195 points (up 1%), the NSE-Nifty today closed higher by around 53 points (up 1%). The BSE Mid cap and the BSE Small cap also notched gains of 1% and 0.5% respectively. Gains were largely seen in banking and auto stocks.

As regards global markets, Asian indices closed mixed today while European indices have opened in the green. The rupee was trading at Rs 55.04 to the dollar at the time of writing.

Pharma stocks closed mixed today. While Glenmark and Dr.Reddy's closed firm, Ranbaxy and Lupin were at the receiving end. As per a leading business daily, Dr.Reddy's has launched 'Ropinirole Hydrochloride' XR (extended release) tablets in the US generics market. This drug is the generic version of SmithKline Beecham's 'Requip XL' and had reported sales of around US$ 58 m for the 12 months period ended March 2012 according to IMS Health. The drug is used for treating Parkinson's disease. This is a positive for the company and will enable it to enhance revenues from the highly competitive US generics market where a continuous launch of new products is necessary for growth. Dr.Reddy's especially has embarked on a strategy of focusing on products with limited competition so as to garner higher revenues and profits.

Cement stocks also closed mixed today. While Madras Cements and Mangalam Cement found favour, Ultratech Cement and Ambuja Cement closed in the red. As per a leading business daily, cement prices have gone up by Rs 10-15 to Rs 300 a bag in select regions in a scenario where demand recovery remains uncertain. However, prices in Maharashtra remained stable at Rs 300 a bag, as the south-west monsoon is expected in the next few days. The rise in operational cost and freight rates has compelled companies to increase prices. Domestic coal prices increased by 60%, while Railways also revised its rates higher in the March quarter. Whether this hike can be sustained remains to be seen as demand and consequently cement sales could fall during the monsoon season. The Competition Commission of India (CCI) had alleged 39 cement companies for influencing cement prices by forming cartels. Though the final report is not out yet, there are chances that guilty companies could be fined. This could have a negative impact on cement prices going forward.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Sustained buying fuels indices". Click here!


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Feb 23, 2018 (Close)